Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RXST

RxSight Inc

Nov 11 • 04:00PM ET

10.23

+0.12 1.19 %

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO SCHA VTWO XHE FFOX VHT DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.88	Insider Own	8.45%	Shs Outstand	41.08M	Perf Week	13.67%
Market Cap	420.62M	Forward P/E	-	EPS next Y	-1.10	Insider Trans	0.00%	Shs Float	37.64M	Perf Month	35.23%
Enterprise Value	204.66M	PEG	-	EPS next Q	-0.34	Inst Own	90.89%	Short Float	11.31%	Perf Quarter	23.10%
Income	-35.73M	P/S	2.96	EPS this Y	-50.92%	Inst Trans	-1.19%	Short Ratio	4.68	Perf Half Y	-22.50%
Sales	142.09M	P/B	1.52	EPS next Y	-3.06%	ROA	-11.54%	Short Interest	4.26M	Perf YTD	-70.24%
Book/sh	6.72	P/C	1.85	EPS next 5Y	-13.67%	ROE	-12.92%	52W High	48.57 -78.94%	Perf Year	-79.88%
Cash/sh	5.53	P/FCF	-	EPS past 3/5Y	26.50% -	ROIC	-12.48%	52W Low	6.32 61.87%	Perf 3Y	-12.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	83.64% 128.61%	Gross Margin	74.98%	Volatility	13.29% 7.12%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.44	EPS Y/Y TTM	-7.15%	Oper. Margin	-32.01%	ATR (14)	0.67	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.44	Sales Y/Y TTM	10.75%	Profit Margin	-25.15%	RSI (14)	67.18	Recom	3.10
Dividend Gr. 3/5Y	- -	Current Ratio	12.74	EPS Q/Q	-50.41%	SMA20	16.88%	Beta	1.14	Target Price	9.67
Payout	-	Debt/Eq	0.04	Sales Q/Q	-14.09%	SMA50	15.77%	Rel Volume	1.37	Prev Close	10.11
Employees	498	LT Debt/Eq	0.04	Earnings	Nov 05 AMC	SMA200	-32.05%	Avg Volume	908.60K	Price	10.23
IPO	Jul 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.12% 19.87%	Trades		Volume	1,247,882	Change	1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-15-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$9
Jul-10-25	Downgrade	Jefferies	Buy → Hold	$9
Jul-09-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$9
Jul-09-25	Downgrade	Oppenheimer	Outperform → Perform
Jul-09-25	Downgrade	BTIG Research	Buy → Neutral
May-19-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$25
Apr-15-25	Initiated	Piper Sandler	Neutral	$18
Apr-09-25	Downgrade	UBS	Buy → Neutral	$16
Apr-04-25	Downgrade	JP Morgan	Overweight → Underweight	$40 → $17
Apr-03-25	Downgrade	BofA Securities	Buy → Underperform	$36 → $22
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36

Show Previous Ratings

Nov-06-25 12:04AM	RxSight Inc (RXST) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Revenue Challenges (GuruFocus.com)
Nov-05-25 06:50PM	RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.33%
04:05PM	RxSight, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:31AM	RxSight Inc (RXST) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-25 04:05PM	RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire)
04:05PM	Loading…
Oct-16-25 04:05PM	RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting (GlobeNewswire) +7.34%
Sep-16-25 08:45AM	Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Sep-15-25 09:32AM	RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction (Insider Monkey)
Sep-09-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire) +9.40%
Sep-05-25 04:09PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Sep-04-25 03:59PM	Investors Urged to Contact Levi & Korsinsky for Information Before September 22, 2025 - RxSight, Inc. (RXST) (Newsfile)
Aug-25-25 04:05PM	RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire) -7.22%
Aug-22-25 08:45AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +6.30%
Aug-14-25 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-13-25 05:14PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile) +13.06%
09:00AM	Loading…
Aug-12-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +10.53%
Aug-07-25 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -7.70%
04:05PM	RxSight, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 08:05AM	RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors (GlobeNewswire)
Aug-01-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Jul-31-25 04:15PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-30-25 04:02PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-25-25 04:54PM	RxSight, Inc. (RXST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-24-25 04:05PM	RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-09-25 03:00AM	RxSight Inc (RXST) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Market Challenges (GuruFocus.com) -37.84%
Jul-08-25 04:05PM	RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Jul-04-25 11:40AM	FMS vs. RXST: Which Stock Is the Better Value Option? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
08:32AM	Loading…
May-23-25 08:32AM	Do Options Traders Know Something About RxSight Stock We Don't? (Zacks)
May-20-25 04:10PM	RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum (GlobeNewswire)
10:55AM	Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued (Insider Monkey)
May-08-25 03:31AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ... (GuruFocus.com) -11.21%
May-07-25 11:04PM	RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript (Seeking Alpha) +6.81%
07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
Apr-04-25 11:46AM	JP Morgan downgrades RxSight on market, competitive pressures (Investing.com)
09:40AM	Block upgraded, Nvidia downgraded: Wall Streets top analyst calls (TipRanks)
03:00AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... (GuruFocus.com)
Apr-03-25 10:39PM	Preliminary Q1 2025 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) -37.94%
05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
03:54PM	RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) (Seeking Alpha)
12:59PM	RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock (GuruFocus.com)
07:32AM	RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges (Benzinga)
Apr-02-25 08:00PM	RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-25-25 04:05PM	RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-26-25 02:15AM	RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-25 05:55PM	RxSight, Inc. (RXST) Misses Q4 Earnings Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance (GlobeNewswire)
01:36AM	What To Expect From RxSight Inc (RXST) Q4 2024 Earnings (GuruFocus.com)
Feb-11-25 04:10PM	RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Goldshleger Ilya	See remarks	Sep 25 '25	Option Exercise	4.27	23,445	99,998	65,691	Sep 26 04:07 PM
Weinberg Eric	See remarks	Jun 02 '25	Option Exercise	3.93	188,002	738,848	195,351	Jun 03 06:18 PM
Thunen Shelley B	See remarks	Apr 14 '25	Option Exercise	4.34	7,792	33,806	38,354	Apr 15 08:57 PM
Fountain Tamara	Director	Mar 12 '25	Sale	25.71	7,000	180,002	24,793	Mar 13 04:46 PM
TAMARA R FOUNTAIN	Director	Mar 12 '25	Proposed Sale	25.71	7,000	180,002		Mar 12 04:02 PM
Maniar Shweta	Director	Jan 22 '25	Sale	30.87	3,519	108,618	7,383	Jan 27 04:40 PM
Maniar Shweta	Director	Jan 22 '25	Proposed Sale	30.87	3,519	108,618		Jan 22 03:56 PM
Corley Jesse Anderson	Director	Jan 16 '25	Buy	31.13	1,767	55,004	3,210	Jan 17 07:08 PM
Corley Jesse Anderson	Director	Jan 15 '25	Buy	31.18	1,443	45,000	1,443	Jan 17 07:08 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Option Exercise	15.08	3,105	46,823	45,351	Dec 03 06:38 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Sale	46.08	3,105	143,078	42,246	Dec 03 06:38 PM
ILYA GOLDSHLEGER	Officer	Nov 29 '24	Proposed Sale	46.08	3,105	143,078		Nov 29 01:29 PM
Maniar Shweta	Director	Nov 26 '24	Sale	45.88	3,782	173,518	10,902	Nov 26 07:26 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Sale	45.88	3,100	142,228	42,246	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Sale	45.00	3,100	139,500	42,246	Nov 26 07:25 PM
ILYA GOLDSHLEGER	Officer	Nov 26 '24	Proposed Sale	45.88	3,100	142,228		Nov 26 04:13 PM
Maniar Shweta	Director	Nov 26 '24	Proposed Sale	45.88	3,782	173,518		Nov 26 02:45 PM
ILYA GOLDSHLEGER	Officer	Nov 22 '24	Proposed Sale	45.00	3,100	139,500		Nov 22 04:15 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Option Exercise	15.08	4,875	73,515	47,121	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Sale	46.00	4,875	224,250	42,246	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Sale	45.00	3,100	139,502	42,246	Nov 18 09:50 PM
ILYA GOLDSHLEGER	Officer	Nov 18 '24	Proposed Sale	45.00	3,100	139,502		Nov 18 04:29 PM
ILYA GOLDSHLEGER	Officer	Nov 15 '24	Proposed Sale	46.00	4,875	224,250		Nov 15 04:18 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	44.84	5,795	259,841	38,438	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	45.00	5,570	250,650	474,141	Nov 14 07:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RXST

RxSight Inc

Upgrade your FINVIZ experience